These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

682 related items for PubMed ID: 25766835

  • 1. Serum klotho: relation to fibroblast growth factor-23 and other regulators of phosphate metabolism in children with chronic kidney disease.
    Sawires HK, Essam RM, Morgan MF, Mahmoud RA.
    Nephron; 2015; 129(4):293-9. PubMed ID: 25766835
    [Abstract] [Full Text] [Related]

  • 2. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
    Wan M, Smith C, Shah V, Gullet A, Wells D, Rees L, Shroff R.
    Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
    [Abstract] [Full Text] [Related]

  • 3. [New markers of cardio-renal links in chronic kidney disease].
    Milovanova LIu, Milovanov IuS, Kozlovskaia LV, Mukhin NA.
    Ter Arkh; 2013 Jan; 85(6):17-24. PubMed ID: 23866594
    [Abstract] [Full Text] [Related]

  • 4. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M, Komaba H, Fukagawa M.
    Contrib Nephrol; 2013 Jan; 180():110-23. PubMed ID: 23652554
    [Abstract] [Full Text] [Related]

  • 5. Soluble α-klotho and its relation to kidney function and fibroblast growth factor-23.
    Scholze A, Liu Y, Pedersen L, Xia S, Roth HJ, Hocher B, Rasmussen LM, Tepel M.
    J Clin Endocrinol Metab; 2014 May; 99(5):E855-61. PubMed ID: 24606097
    [Abstract] [Full Text] [Related]

  • 6. Fibroblast growth factor 23/klotho axis in chronic kidney disease.
    Nitta K, Nagano N, Tsuchiya K.
    Nephron Clin Pract; 2014 May; 128(1-2):1-10. PubMed ID: 25402964
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Circulating α-klotho levels in CKD and relationship to progression.
    Kim HR, Nam BY, Kim DW, Kang MW, Han JH, Lee MJ, Shin DH, Doh FM, Koo HM, Ko KI, Kim CH, Oh HJ, Yoo TH, Kang SW, Han DS, Han SH.
    Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Klotho/FGF23 Axis in CKD.
    Tsuchiya K, Nagano N, Nitta K.
    Contrib Nephrol; 2015 Jun; 185():56-65. PubMed ID: 26023015
    [Abstract] [Full Text] [Related]

  • 11. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
    Milovanova LY, Milovanov YS, Kudryavtseva DV, Markina MM, Milovanova SY, Kozlovskaya LV, Lebedeva MV, Beketov VD, Moiseev SV, Mukhin NA, Fomin VV, Svistunov AA.
    Ter Arkh; 2015 Jun; 87(6):10-16. PubMed ID: 26281189
    [Abstract] [Full Text] [Related]

  • 12. Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients.
    Lin HH, Liou HH, Wu MS, Lin CY, Huang CC.
    Nephrology (Carlton); 2014 Nov; 19(11):672-8. PubMed ID: 25113414
    [Abstract] [Full Text] [Related]

  • 13. [Significance of the morphogenetic proteins FGF-23 and Klotho as predictors of prognosis of chronic kidney disease].
    Milovanova LIu, Milovanov IuS, Kozlovskaia LV, Mukhin NA.
    Ter Arkh; 2014 Nov; 86(4):36-44. PubMed ID: 24864466
    [Abstract] [Full Text] [Related]

  • 14. Serum soluble Klotho protein level is associated with residual diuresis in incident peritoneal dialysis patients.
    Golembiewska E, Safranow K, Kabat-Koperska J, Myślak M, Ciechanowski K.
    Acta Biochim Pol; 2013 Nov; 60(2):191-4. PubMed ID: 23748218
    [Abstract] [Full Text] [Related]

  • 15. [Effect of Ronghuang Granule on serum FGF23, FGFRs and Klotho in non-dialysis patients with CKD-MBD and kidney deficiency and damp-heat syndrome].
    Hu S, Wang D, Zhang R, Cao Y, Jin H, Mao Y, Wei L, Ren K, Zhang X, Wang Y.
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec 30; 38(12):1427-1432. PubMed ID: 30613009
    [Abstract] [Full Text] [Related]

  • 16. Role of Klotho in aging, phosphate metabolism, and CKD.
    John GB, Cheng CY, Kuro-o M.
    Am J Kidney Dis; 2011 Jul 30; 58(1):127-34. PubMed ID: 21496980
    [Abstract] [Full Text] [Related]

  • 17. Klotho gene, phosphocalcic metabolism, and survival in dialysis.
    Torres PU, Prié D, Beck L, De Brauwere D, Leroy C, Friedlander G.
    J Ren Nutr; 2009 Jan 30; 19(1):50-6. PubMed ID: 19121771
    [Abstract] [Full Text] [Related]

  • 18. Association of klotho gene polymorphism and the regulation of calcium-phosphate metabolism disorders in patients with end-stage renal disease.
    Zeng QY, Xia ZY, Tong YS, Sun L, Mou HB, Chen R, Bi GY, Liu CH.
    Nephrology (Carlton); 2019 Oct 30; 24(10):1001-1008. PubMed ID: 30537427
    [Abstract] [Full Text] [Related]

  • 19. [Mineral metabolism in patients on chronic peritoneal dialysis].
    Ceballos O ML, Rojo L A, Azócar P M, Ibacache M MJ, Delucchi B A, Quiroz Z L, Irarrázabal M C, Delgado B I, Ugarte P F, Cano Sch F.
    Rev Chil Pediatr; 2014 Feb 30; 85(1):31-9. PubMed ID: 25079181
    [Abstract] [Full Text] [Related]

  • 20. Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients.
    Zheng S, Chen Y, Zheng Y, Zhou Z, Li Z.
    Eur J Med Res; 2018 Apr 17; 23(1):18. PubMed ID: 29665846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.